Xenobiotics or biological response modifiers? Methotrexate remains the anchor drug for rheumatoid arthritis
- PMID: 9844756
Xenobiotics or biological response modifiers? Methotrexate remains the anchor drug for rheumatoid arthritis
Comment on
-
Cyclosporine A in the treatment of early rheumatoid arthritis. A prospective, randomized 24-month study.Clin Exp Rheumatol. 1998 Nov-Dec;16(6):695-701. Clin Exp Rheumatol. 1998. PMID: 9844762 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical